Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
Ursu R, Taillibert S, Banissi C, Vicaut E, Bailon O, Le Rhun E, Guillamo JS, Psimaras D, Tibi A, Sacko A, Marantidou A, Belin C, Carpentier AF. Ursu R, et al. Among authors: carpentier af. Cancer Sci. 2015 Sep;106(9):1212-8. doi: 10.1111/cas.12724. Epub 2015 Jul 29. Cancer Sci. 2015. PMID: 26094710 Free PMC article. Clinical Trial.
Initial chemotherapy in gliomatosis cerebri.
Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY; ANOCEF group. Sanson M, et al. Neurology. 2004 Jul 27;63(2):270-5. doi: 10.1212/01.wnl.0000129985.39973.e4. Neurology. 2004. PMID: 15277619 Clinical Trial.
[Cancer immunotherapy with CpG-ODN].
Carpentier AF. Carpentier AF. Med Sci (Paris). 2005 Jan;21(1):73-7. doi: 10.1051/medsci/200521173. Med Sci (Paris). 2005. PMID: 15639024 Free article. Review. French.
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Carpentier A, Laigle-Donadey F, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF. Carpentier A, et al. Among authors: carpentier af. Neuro Oncol. 2006 Jan;8(1):60-6. doi: 10.1215/S1522851705000475. Neuro Oncol. 2006. PMID: 16443949 Free PMC article. Clinical Trial.
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K. Kaloshi G, et al. Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545
Cerebrospinal fluid study in paraneoplastic syndromes.
Psimaras D, Carpentier AF, Rossi C; PNS Euronetwork. Psimaras D, et al. Among authors: carpentier af. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):42-5. doi: 10.1136/jnnp.2008.159483. Epub 2009 Mar 25. J Neurol Neurosurg Psychiatry. 2010. PMID: 19324868
Steroid requirements during radiotherapy for malignant gliomas.
Marantidou A, Levy C, Duquesne A, Ursu R, Bailon O, Coman I, Belin C, Carpentier AF. Marantidou A, et al. Among authors: carpentier af. J Neurooncol. 2010 Oct;100(1):89-94. doi: 10.1007/s11060-010-0142-8. Epub 2010 Feb 26. J Neurooncol. 2010. PMID: 20186461
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.
Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, Barrié M, Meng Y, Richard M, Parizot C, Laigle-Donadey F, Gorochov G, Psimaras D, Sanson M, Tibi A, Chinot O, Carpentier AF. Carpentier A, et al. Among authors: carpentier af. Neuro Oncol. 2010 Apr;12(4):401-8. doi: 10.1093/neuonc/nop047. Epub 2010 Jan 25. Neuro Oncol. 2010. PMID: 20308317 Free PMC article. Clinical Trial.
215 results